73 related articles for article (PubMed ID: 18978749)
1. Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56
Shereck E; Day NS; Awasthi A; Ayello J; Chu Y; McGuinn C; van de Ven C; Lim MS; Cairo MS
Innate Immun; 2019 Jul; 25(5):294-304. PubMed ID: 31068047
[TBL] [Abstract][Full Text] [Related]
2. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
Alexander TB; Wang L; Inaba H; Triplett BM; Pounds S; Ribeiro RC; Pui CH; Rubnitz JE
Cancer; 2017 Oct; 123(19):3791-3798. PubMed ID: 28556917
[TBL] [Abstract][Full Text] [Related]
3. Medullary allotransplant in acute myeloblastic leukemia in a child.
Buga Corbu V; Glűck A; Arion C
J Med Life; 2014 Sep; 7(3):450-4. PubMed ID: 25408774
[TBL] [Abstract][Full Text] [Related]
4. Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
de Berranger E; Cousien A; Petit A; Peffault de Latour R; Galambrun C; Bertrand Y; Salmon A; Rialland F; Rohrlich PS; Vannier JP; Lutz P; Yakouben K; Duhamel A; Bruno B; Michel G; Dalle JH
Bone Marrow Transplant; 2014 Mar; 49(3):382-8. PubMed ID: 24317131
[TBL] [Abstract][Full Text] [Related]
5. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland.
Balwierz W; Pawinska-Wasikowska K; Klekawka T; Czogala M; Matysiak M; Fic-Sikorska B; Adamkiewicz-Drozynska E; Maciejka-Kapuscinska L; Chybicka A; Potocka K; Wachowiak J; Skalska-Sadowska J; Kowalczyk J; Wojcik B; Wysocki M; Koltan S; Krawczuk-Rybak M; Muszynska-Roslan K; Mlynarski W; Stolarska M; Urasinski T; Kamienska E; Szczepanski T; Tomaszewska R; Sobol G; Mizia-Malarz A; Karolczyk G; Podhorecka J; Wieczorek M; Karpinska-Derda I; Badowska W; Moryl-Bujakowska A
Memo; 2013 Feb; 6(1):54-62. PubMed ID: 23565126
[TBL] [Abstract][Full Text] [Related]
6. Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.
Leung W; Pui CH; Coustan-Smith E; Yang J; Pei D; Gan K; Srinivasan A; Hartford C; Triplett BM; Dallas M; Pillai A; Shook D; Rubnitz JE; Sandlund JT; Jeha S; Inaba H; Ribeiro RC; Handgretinger R; Laver JH; Campana D
Blood; 2012 Jul; 120(2):468-72. PubMed ID: 22517895
[TBL] [Abstract][Full Text] [Related]
7. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.
Leung W; Campana D; Yang J; Pei D; Coustan-Smith E; Gan K; Rubnitz JE; Sandlund JT; Ribeiro RC; Srinivasan A; Hartford C; Triplett BM; Dallas M; Pillai A; Handgretinger R; Laver JH; Pui CH
Blood; 2011 Jul; 118(2):223-30. PubMed ID: 21613256
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transplantation in acute myelogenous leukemia in first remission: what are the options?
Mathews V; DiPersio JF
Curr Hematol Rep; 2004 Jul; 3(4):235-41. PubMed ID: 15217552
[TBL] [Abstract][Full Text] [Related]
9. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
[TBL] [Abstract][Full Text] [Related]
10. Place of HSCT in treatment of childhood AML.
Klingebiel T; Reinhardt D; Bader P;
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S7-9. PubMed ID: 18978749
[TBL] [Abstract][Full Text] [Related]
11. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.
Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895
[TBL] [Abstract][Full Text] [Related]
12. Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?
Gassas A; Afzal S; Ishaqi MK; Finkelstein-Shechter T; Rojas M; Dupuis A; Sung L; Doyle J
Bone Marrow Transplant; 2008 Sep; 42(6):393-6. PubMed ID: 18587434
[TBL] [Abstract][Full Text] [Related]
13. Early lymphocyte recovery after allogeneic hematopoietic SCT is associated with significant GVL effect in pediatric ALL but not acute myelogenous leukemia-Update study.
Afzal S; Ishaqi MK; Dupuis A; Doyle J; Gassas A
Bone Marrow Transplant; 2009 Dec; 44(12):799-804. PubMed ID: 19421173
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.
Gassas A; Ishaqi MK; Afzal S; Finkelstein-Shechter T; Dupuis A; Doyle J
Bone Marrow Transplant; 2008 Jun; 41(11):941-5. PubMed ID: 18264141
[TBL] [Abstract][Full Text] [Related]
15. Autologous hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trials.
Wang J; Ouyang J; Zhou R; Chen B; Yang Y
Acta Haematol; 2010; 124(2):61-71. PubMed ID: 20616541
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
